Compounds > cytidine triphosphate
Page last updated: 2024-08-17

cytidine triphosphate and Cancer of Pancreas

cytidine triphosphate has been researched along with Cancer of Pancreas in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bapiro, TE; Chen, N; Ellenrieder, V; Frese, KK; Gopinathan, A; Gress, TM; Hessmann, E; Heuchel, R; Jodrell, DI; Johnsen, SA; Kari, V; Klein, L; Li, X; Löhr, JM; Neesse, A; Patzak, MS; Ramu, I; Richards, FM; Verbeke, C1
Barten-Van Rijbroek, AD; Kal, HB; Leen, R; Rodermond, HM; Van Bree, C; Van Kuilenburg, AB1
Huang, L; Kim, WY; Zhang, Y1
Leen, R; Medema, J; Rodermond, H; van Bree, C; van Kuilenburg, A1
Chang, EY; Hahn, TM; Hertel, LW; Lawrence, TS; Shewach, DS1

Other Studies

5 other study(ies) available for cytidine triphosphate and Cancer of Pancreas

ArticleYear
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer.
    Gut, 2018, Volume: 67, Issue:3

    Topics: 5'-Nucleotidase; Actins; Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cytidine Triphosphate; Deoxycytidine; Fibroblasts; Floxuridine; Gemcitabine; Humans; Liver; Liver Neoplasms; Mice; Pancreatic Neoplasms; Primary Cell Culture; Tumor Microenvironment

2018
Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.
    International journal of oncology, 2009, Volume: 34, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Cytidine; Cytidine Triphosphate; Deoxycytidine; Disease Models, Animal; Drug Synergism; Female; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Middle Aged; Pancreatic Neoplasms; Rats; Rats, Inbred BN

2009
Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.
    Biomaterials, 2013, Volume: 34, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytidine Triphosphate; Enzyme Activation; Female; Humans; Lipids; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Particle Size; Phosphates; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; S Phase; Static Electricity; Xenograft Model Antitumor Assays

2013
Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.
    British journal of cancer, 2008, Apr-08, Volume: 98, Issue:7

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cytidine; Cytidine Triphosphate; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Pancreatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents

2008
Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
    International journal of radiation oncology, biology, physics, 1996, Mar-01, Volume: 34, Issue:4

    Topics: Adenosine Triphosphate; Cell Cycle; Cell Survival; Cytidine Triphosphate; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Guanosine Triphosphate; Humans; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Thymine Nucleotides; Tumor Cells, Cultured

1996